Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival

被引:10
|
作者
Wohnrath, Durval R. [1 ]
Araujo, Raphael L. C. [1 ,2 ,3 ,4 ]
机构
[1] Barretos Canc Hosp, Dept Upper Gastrointestinal & Hepato Pancreto Bil, Barretos, SP, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Digest Surg, Rua Botucatu 740, BR-04023062 Sao Paulo, SP, Brazil
[3] United Hlth Grp, Amer Med Serv Brazil, Dept Oncol, Sao Paulo, SP, Brazil
[4] Hosp Israelita Albert Einstein, Dept Oncol, Sao Paulo, SP, Brazil
关键词
gastric cancer; lymphadenectomy; oncologic outcomes; surgery; survival; EXAMINED LYMPH-NODES; PARAAORTIC LYMPHADENECTOMY; SELECTING PATIENTS; N-RATIO; DISSECTION; D2; CHEMORADIOTHERAPY; ADENOCARCINOMA; SUPERIORITY; SURGERY;
D O I
10.1002/jso.25755
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionThis study addressed whether the positive node-ratio (N-ratio) for patients who underwent curative-intent treatment was an independent prognostic factor of overall survival (OS) for gastric adenocarcinoma (GA). MethodsConsecutive patients who underwent gastrectomy for GA with at least 15 harvested nodes were evaluated for 5-year OS. The best threshold was determined using the area under an receiver operating characteristic (ROC) curve. Univariate and multivariate models were assessed looking for independent prognostic factors for OS. ResultsFrom 1994 to 2015, 398 consecutive patients were evaluated. The N-ratio >= 11% had an accuracy of 0.764, the sensitivity of 71.1%, the specificity of 81.7%, positive predictive value (PPV) of 91.7%, and odds ratio (OR) of 11. After multivariate analysis for OS, age >= 70 years (HR 1.44), need for total gastrectomy (HR 1.45), need for extended resection (HR 1.7), and N-ratio >= 11% (HR 3.7) were unfavorable prognostic factors. D2 lymphadenectomy (HR 0.53) was a protective factor. The median OS according to N-ratio was 14 months for N-ratio >11 vs 58 months for N-ratio <11%. ConclusionThe N-ratio >= 11% was an independent negative prognostic factor for patients who underwent treatment for GA with curative intent. The N-ratio >= 11% presented high specificity, high PPV and high OR for risk of death for 5 years after surgery.
引用
收藏
页码:777 / 783
页数:7
相关论文
共 50 条
  • [41] Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer
    Lucy Jankova
    Owen F Dent
    Charles Chan
    Pierre Chapuis
    Stephen J Clarke
    BMC Cancer, 13
  • [42] Can the ratio of metastatic to examined lymph nodes (N ratio) be used as an independent prognostic factor in patients with gastric cancer? Is the hypothetical TRM (tumor-ratio-metastasis) staging system an alternative to the TNM (tumor-node-metastasis) staging system?
    Ilhan, Enver
    Zengel, Baha
    Simsek, Hatice
    Canpolat, Selin
    Yildirim, Mehmet
    PRZEGLAD GASTROENTEROLOGICZNY, 2013, 8 (04): : 247 - 256
  • [43] Lateral lymph node dissection can increase overall survival and 5-year survival rate of rectal cancer patients: A meta-analysis
    Zou, Boyuan
    Ning, Ning
    Yan, Yichao
    Zhang, Yankai
    ONCOLOGY LETTERS, 2024, 27 (02)
  • [44] Increasing disparities in the proportions of active treatment and 5-year overall survival over time by age groups among older patients with gastric cancer in Korea
    Zhang, Hyun-Soo
    Choi, Dong-Woo
    Kim, Han Sang
    Kang, Hye Jung
    Jhang, Hoyol
    Jeong, Wonjeong
    Nam, Chung Mo
    Park, Sohee
    FRONTIERS IN PUBLIC HEALTH, 2023, 10
  • [45] Negative Lymph Node Is an Independent Prognostic Factor for Stage III Gastric Cancer Patients After Curative Gastrectomy: A Surveillance, Epidemiology, and End Results-Based Study
    Liu, Linmei
    Ren, Jigang
    Wang, Guan
    Cui, Yingjuan
    Li, Fang
    Wang, Daxue
    Lei, Xiao
    AMERICAN SURGEON, 2023, 89 (11) : 4413 - 4423
  • [46] The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment
    Aoyama, Toru
    Maezawa, Yukio
    Hashimoto, Itaru
    Hara, Kentaro
    Tamagawa, Ayako
    Kazama, Keusike
    Kato, Aya
    Cho, Haruhiko
    Nakazono, Masato
    Numata, Masakatsu
    Kawahara, Shinnosuke
    Tanabe, Mie
    Morita, Jyunya
    Oshima, Takashi
    Saito, Aya
    Yukawa, Norio
    Rino, Yasushi
    ANTICANCER RESEARCH, 2024, 44 (04) : 1629 - 1636
  • [47] Preoperative neutrophil-to-lymphocyte ratio behaves as an independent prognostic factor even in patients with postoperative complications after curative resection for gastric cancer
    Jaume Tur-Martínez
    Javier Osorio
    Noelia Pérez-Romero
    Noelia Puértolas-Rico
    Manuel Pera
    Salvadora Delgado
    Joaquín Rodríguez-Santiago
    Langenbeck's Archives of Surgery, 2022, 407 : 1017 - 1026
  • [48] Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent
    Yuexiang Liang
    Liangliang Wu
    Xiaona Wang
    Xuewei Ding
    Hongmin Liu
    Bin Li
    Baogui Wang
    Yuan Pan
    Rupeng Zhang
    Ning Liu
    Han Liang
    ChineseJournalofCancerResearch, 2015, 27 (06) : 580 - 587
  • [49] Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study
    Kim, Jin-Soo
    Kim, Min-A
    Oh, Do-Youn
    Lee, Se-Hoon
    Kim, Dong-Wan
    Im, Seock-Ah
    Kim, Woo Ho
    Yang, Han-Kwang
    Heo, Dae Seog
    Bang, Yung-Jue
    Lee, Kuhn-Uk
    Kim, Tae-You
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (02) : 245 - 252
  • [50] Prognostic value of cervical lymph node metastasis ratio in Asian papillary thyroid carcinoma 5-year relapse-free survival: a meta-analysis
    Chen, Jumin
    Bai, Junyun
    Yang, Kunxian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 1401 - 1410